Showing results (121-130 of 273) with videos related to
Sort By:
Pageof 28
Annals of Emergency Medicine|January 16, 2019
The Effect of Tranexamic Acid on Functional Outcomes: An Exploratory Analysis of the CRASH-2 Randomized Controlled TrialDaniel K Nishijima, Nathan Kuppermann, Ian Roberts, et al.Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|December 27, 2018
What concentration of tranexamic acid is needed to inhibit fibrinolysis? A systematic review of pharmacodynamics studiesRoberto Picetti, Haleema Shakur-Still, Robert L Medcalf, et al.BMC Pregnancy and Childbirth|May 31, 2018
Risk factors for peripartum hysterectomy among women with postpartum haemorrhage: analysis of data from the WOMAN trialSumaya Huque, Ian Roberts, Bukola Fawole, et al.BMC Pregnancy and Childbirth|June 9, 2018
The impact of early outcome events on the effect of tranexamic acid in post-partum haemorrhage: an exploratory subgroup analysis of the WOMAN trialAmy Brenner, Haleema Shakur-Still, Rizwana Chaudhri, et al.Plos One|June 4, 2020
Risk factors for blood transfusion in traumatic and postpartum hemorrhage patients: Analysis of the CRASH-2 and WOMAN trialsDavid A Kolin, Haleema Shakur-Still, Adenike Bello, et al.Trials|April 20, 2010
The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trialHaleema Shakur, Diana Elbourne, Metin Gülmezoglu, et al.BMC Public Health|June 20, 2012
The weight of nations: an estimation of adult human biomassSarah Catherine Walpole, David Prieto-Merino, Phil Edwards, et al.Journal of Biomedical Informatics|June 19, 2009
Building a semantically annotated corpus of clinical textsAngus Roberts, Robert Gaizauskas, Mark Hepple, et al.Trials|February 2, 2017
Tranexamic acid in bleeding trauma patients: an exploration of benefits and harmsIan Roberts, Phil Edwards, David Prieto, et al.British Journal of Anaesthesia|May 21, 2022
Use of tranexamic acid in major trauma: a sex-disaggregated analysis of the Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage (CRASH-2 and CRASH-3) trials and UK trauma registry (Trauma and Audit Research Network) dataTim Nutbeam, Ian Roberts, Lauren Weekes, et al.Pageof 28